Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RT Nominal up3.310 +0.020 (+0.608%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties289,342-59.856%720,754705,626308,559563,395
Property, plant, equip. & others8,080,9074.141%7,759,5927,154,2986,870,2886,379,337
Land & other Lease Assets1,831,25422.772%1,491,5911,361,7641,521,9161,253,886
Intangible Assets2,908,96151.948%1,914,4501,711,9461,013,6361,413,138
Interests in Asso. & JCEs12,243,675-7.232%13,198,15714,266,3965,050,637808,443
Other Non-current Assets14,445,14910.735%13,044,83511,840,1299,651,1992,182,898

39,799,2884.380%38,129,37937,040,15924,416,23512,601,097
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories1,993,472-14.401%2,328,8441,937,7411,880,0511,658,597
Trade Receivables4,510,195-2.764%4,638,3964,220,6672,914,0772,712,209
Cash & Bank Balances9,451,878-21.667%12,066,21710,568,81211,259,08411,911,210
Other Current Assets6,937,2800.519%6,901,4486,775,9586,740,9918,631,079
Assets Held for Sale912,706--0000

23,805,531-8.210%25,934,90523,503,17822,794,20324,913,095
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables1,334,703-18.484%1,637,3511,693,1521,947,8021,809,445
S-T Debt & Leases11,207,42815.257%9,723,8416,585,0381,581,524689,828
Other Current Liabilities9,825,78511.790%8,789,4857,066,8297,414,2135,623,752
Liab asso w/ Assets Held for Sale238,859--0000

22,606,77512.189%20,150,67715,345,01910,943,5398,123,025
Net Current Assets1,198,756-79.275%5,784,2288,158,15911,850,66416,790,070
Total Assets Less Current Liabilities40,998,044-6.639%43,913,60745,198,31836,266,89929,391,167
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases1,372,816-67.760%4,258,1225,532,47512,628,3007,926,072
Other Non-current Liabilities1,455,275-14.992%1,711,9371,936,8201,219,041903,913

2,828,091-52.629%5,970,0597,469,29513,847,3418,829,985
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital414,615-0.068%414,899415,440415,895278,451
  Reserves30,059,8542.481%29,332,13629,875,67616,331,26514,670,794
  Others0--0000
Shareholders' Funds30,474,4692.445%29,747,03530,291,11616,747,16014,949,245
Non-controlling Interests7,695,484-6.113%8,196,5137,437,9075,672,3985,611,937
Others0--0000

38,169,9530.597%37,943,54837,729,02322,419,55820,561,182
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments535,546-70.432%1,811,239950,0381,224,839964,040
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 15/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,017,162
%Change139.689%
EPS / (LPS)RMB 0.164
NBV Per Share (¥)RMB 1.748
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.